1. Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. Treatment improvement protocol (TIP) series 40. Department of Health and Human Services publication no. (SMA) 04-3939,2004
2. Center for Behavioral Health Statistics and Quality. Behavioral health trends in the United States: results from the 2014 National Survey on Drug Use and Health (HHS publication no. SMA 15-4927, NSDUH Series H-50). 2015. Available at: http://www.samhsa.gov/data/. Accessed July 10, 2017.
3. Pharmacokinetics of drugs in pregnancy;Feghali;Semin Perinatol,2015
4. Preliminary buprenorphine sublingual tablet pharmacokinetic data in plasma, oral fluid, and sweat during treatment of opioid-dependent pregnant women;Concheiro;Ther Drug Monit,2011
5. Dose-adjusted plasma concentrations of sublingual buprenorphine are lower during than after pregnancy;Bastian;Am J Obstet Gynecol,2017